Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC).

Autor: Sitthideatphaiboon P; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand., Somlaw N; Division of Clinical Nutrition, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn, Memorial Hospital, 1873 Rama IV Road, Pathumwan, Bangkok, Thailand., Zungsontiporn N; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand., Ouwongprayoon P; Department of Radiology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Sukswai N; Precision Pathology of Neoplasia Research Group, Department of Pathology, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Korphaisarn K; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Poungvarin N; Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi, Bangkok, Thailand., Aporntewan C; Department of Mathematics and Computer Science & Omics Sciences and Bioinformatics Center, Faculty of Science, Chulalongkorn University, Bangkok, 10330, Thailand., Hirankarn N; Center of Excellence in Immunology and Immune-mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Vinayanuwattikun C; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand., Chanida V; Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and The King Chulalongkorn Memorial Hospital, Bangkok, 10330, Thailand. Chanida.Vi@chula.ac.th.

Publikováno v: Scientific reports [Sci Rep] 2024 Nov 13; Vol. 14 (1), pp. 27791. Date of Electronic Publication: 2024 Nov 13.

Loss of CDX-2 expression is an independent poor prognostic biomarker in patients with early-stage deficient mismatch repair colorectal cancer.

Autor: Korphaisarn K; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Sukhokanjanachusak K; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Pongpaibul A; Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Chinswangwatanakul V; Division of General Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Akewanlop C; Division of Medical Oncology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Publikováno v: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Jun; Vol. 18 (3), pp. 249-258. Date of Electronic Publication: 2021 Jun 23.

EP.12A.14 Multicentered Real-World Evidence of Osimertinib Treatment in EGFR-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC) In Thailand.

Autor: Thamrongjirapat, T., Sitthideatphaiboon, P., Oranratnachai, S., Khiewngam, K., Maneenil, K., Prasongsook, N., Korphaisarn, K., Wangsubtawee, S., Rattanaphom, A., Reungwetwattana, T., Sriuranpong, V.

Publikováno v: Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS624-S625, 2p

1206MO ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK+ non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)

Autor: Solomon, B.J., Wu, Y-L., Dziadziuszko, R., Barlesi, F., Nishio, M., Ahn, J.S., Horinouchi, H., Hochmair, M.J., de Marinis, F., Migliorino, M.R., Kurochkin, A., Harputluoglu, H., Planchard, D., Korphaisarn, K., Han, J-Y., Lohmann, T., Cardona Gavaldon, A., Archer, V.R., Nowicka, M., Noe, J.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S775-S775

1302P Treatment outcomes and safety of durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: A real-world, multi-center observational study

Autor: Sitthideatphaiboon, P., Reungwetwattana, T., Jaruhathai, S., Supavavej, A., Limpawittayakul, P., Maneenil, K., Korphaisarn, K., Suksombooncharoen, T., Thongthieang, L., Sathitruangsak, C., Chayangsu, C., Ratanabunjerdkul, H., Prasongsook, N., Sriuranpong, V.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S750-S750